Catalyzing Your Communication to Increase HPV Vaccination
Join us as we explore a new communication landscape with a series of three FREE virtual webinars. Part 3: HPV Communications – Evaluating Your Impact.
June 14, 2023, 12:00 – 1:00 PM EST.
It’s a NEW digital platform that facilitates shared learning for organizations & agencies working toward increasing HPV vaccination in higher-burden, lower-resourced communities.Get Tools and Resources HERE!
National Call-to-Action Letter
“Start Recommending HPV Vaccination
at Age 9”
The National Age 9 CTA Letter can be disseminated to providers, payors, health systems, coalitions, and public health partners statewide to activate efforts and standardize HPV vaccinations starting at age 9.Download the Age 9 CTA Letter Today!
2023 Human Vaccines & Immunotherapeutics Collection – HPV Vaccination Starting at Age 9
Read NEW evidence recently published on the impact of initiating HPV vaccination at ages 9-10, including population studies, quality improvement projects, brief reports and commentaries from experts in the field.READ THE FULL COLLECTION NOW!
Don’t Miss This Cervivor Podcast Episode!
Lead with Action: An Impactful Discussion on Closing the Cervical Cancer Disparity Gap with Kimberly Williams & Julia Neely.Check it out TODAY!
2023 HPVRT Action Plan and Key Accomplishments Report
Learn more about how we are successfully working to disseminate the best and promising practices and catalyzing key audiences to reach our goal of preventing HPV cancers in the U.S.READ THE FULL REPORT NOW
St. Jude Prevention Report
The St. Jude HPV Cancer Prevention Program recently released an initial summary report outlining public policy recommendations based on drivers of HPV vaccination coverage in the United States.
Read more about how $26 million could be saved annually!Read More About It!
ACS HPV Vaccination 2021 Impact Report
HPV VACs Program: Vaccinate Adolescents against Cancers. This report summarizes the national and regional activities of the American Cancer Society to increase HPV vaccination.
about advancing HPV cancer prevention during a pandemic.
Best Practices from an HPV Learning Collaborative
We are proud to release a new summary report and infographic on our partnership with AMGA to host an HPV learning collaborative in 8 health systems.Learn Best Practices
CDC U.S. Cancer Statistics – HPV Data Briefs
U.S. Cancer Statistics Report on Cancers Associated with HPV, from 2015 to 2019 – An estimated 47,199 new cases of HPV-associated cancers occurred in the United States each year.Read the Full Report Now!
The Pink Book Web-on-Demand Series
Katheryn Baker, MPH, BSN, PHNA-BC, RN-BC, Nurse Educator (NCIRD) (CDC). An update on this vaccine-preventable disease and the vaccine used to protect against it.See the Course Session
Twitter feed is not available at the moment.